CIRRHOTIC CARDIOMYOPATHY
Clinical trials for CIRRHOTIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CIRRHOTIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CIRRHOTIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop liver failure: two drugs better than one?
Disease control Recruiting nowThis study is testing if adding the diabetes/heart drug empagliflozin to the standard heart drug carvedilol can better protect people with liver cirrhosis and a stiff heart. The main goal is to see if this combination prevents serious liver complications (like internal bleeding o…
Matched conditions: CIRRHOTIC CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Heart scan vs. standard protocol: a new battle in sepsis care for liver patients
Disease control Recruiting nowThis study is comparing two ways to give fluids and medications to liver patients with severe, life-threatening infections (sepsis). One method uses a bedside heart ultrasound to carefully guide treatment, while the other follows a standard protocol. The goal is to see if the ult…
Matched conditions: CIRRHOTIC CARDIOMYOPATHY
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC